Company
Spire Healthcare Group Plc
LON:SPI
Spire Healthcare is a leading provider of private healthcare, with 39* private hospitals and 13 clinics across England, Wales and Scotland. The company is built on a proud heritage of over 25 years experience of running successful private hospitals.
79 stories
Spire Healthcare CFO in hospital after ‘serious’ cycling accident
"We are very pleased and relieved that Jitesh is recovering well”
Private hospital group Spire hired to provide further COVID-19 support for NHS
The agreement is expected to cover the next three months
Investments and investor services
Major Spire investor rejects raised takeover offer
Toscafund, which owns a 5.4% stake in the private hospital chain, said the 250p per share offer from Ramsay Health Care “continues to undervalue Spire substantially”
Investments and investor services
Spire Healthcare takeover looks far from done deal as Fidelity rejects Ramsay offer
According to Sky, Fidelity is hoping its move will encourage other objectors.
Spire Healthcare recommends £999mln cash offer by Australia's Ramsay Health Care
The takeover was also recommended by majority shareholder Mediclinic
Spire Healthcare weighed by NHS reforms with earnings not improving until second half, says broker
The private hospital operator has rebounded strongly over the past six months but uncertainty looms
Spire Healthcare in favour at RBC as non-COVID-19 activity picks up
RBC forecasts are 42% higher than the consensus for earnings in 2021
Spire Healthcare upgraded to ‘overweight’ by JP Morgan due to pent-up demand
The private hospital operator is well-placed to deliver capacity, according to analysts
Spire Healthcare Group swings to loss, chairman announces retirement
Trading is forecast to return to 2019 levels in 2021
Spire Healthcare agrees with NHS England to go back to normal business
Spire will continue providing NHS elective care to reduce waiting lists but it will increase private activity in its 35 English hospitals
Spire Healthcare finally a ‘buy’ for Liberum over long-term prospects
Analysts said the massively increased waiting lists are likely to provide better long-term revenue visibility than ever
Spire Healthcare to turn all private hospitals over to NHS to cope with coronavirus
Spire will be paid enough to cover costs for its services, including operating costs, overheads, use of assets, rent and interest
Spire prepares as NHS block-buys private hospital capacity for coronavirus surge
Private hospital staff and facilities will be “flexibly available to you for urgent surgery, as well as for repurposing their beds, operating theatres and recovery facilities to provide respiratory support for Covid-19 patients,” NHS boss S
Archive
Frontier IP perks up on the back of coronavirus vaccine update
A look at some of the major movers on Friday the 13th
Spire Healthcare offers support as NHS asks for help with coronavirus
Spire owns 39 hospitals and eight clinics across England, Wales and Scotland
Spire swings to first half profit as cost-cutting begins to pay off
The group slashed its capital investments by 41% in the six months, while targeted marketing campaigns had lifted revenues from private medical insurance
UBS thinks Spire will struggle to convince more people to leave the NHS and go private
According to UBS research, the NHS’s offering is “generally of high quality”, while dissatisfaction over wait times has stabilised and the public believe healthcare should be government-funded
Spire Healthcare in rude health so far this year
There was no repeat of the profit warnings seen last year, with Spire confirming it has made a solid start to the year and remains on track to meet full-year expectations
Mediclinic jumps as profit fall likely to be better-than-feared
Full-year results are due out next month, and Mediclinic expects underlying earnings to fall by 3.5%, although analysts had thought they might tumble by as much as 4.8%
Credit Suisse cuts Spire Healthcare to 'underperform', halves target price on softer NHS revenues
The Swiss Bank's analysts cut Spire's earnings per share estimates for 2018-2020 by 14-33%, while expecting the group to downgrade its underlying earnings (EBITDA) target for 2022
Spire shares slide as Jefferies downgrades to ‘underperform’ on “increasingly ambitious” targets
The broker said that after targeting £200mln+ in underlying earnings (EBITDA) by 2022, it was becoming “increasingly clear” that the targets and timelines were "likely to slip”
Spire blames NHS for “disappointing” first-half profits slump and weak outlook
Britain’s second-largest healthcare firm said a “prolonged decline” in NHS volumes eroded margins in the first half as it chopped its forecasts for the year
FTSE 100 closes marginally lower as stocks look rudderless
The UK pound is off 0.14% against the US dollar, and flat against the Euro at the time of writing
Archive
Ocado update eyed for further contract win details after blockbuster Kroger deal
Aside the Ocado update, trading news will also arrive from vehicle hire form Northgate, and FTSE 250-listed Spire Healthcare
Spire Healthcare shares dive on profit warning, lower NHS referrals
The FTSE 250-listed firm reported a steep fall in first-half underlying earnings (EBITDA) to £66mln from £83.4mln in 2017 on annual revenue 1.1% lower at £475mln
Mediclinic in red after write-downs at Spire and in Switzerland
Mediclinic’s bid for the outstanding 70% of Spire was rejected by the UK healthcare group
Investments and investor services
FTSE 100 suffers triple-digit fall as investors fret over a trade war coinciding with Brexit
Fears of a trade war have rattled investors, with minerals companies particularly hard hit
Archive
LSE to report rise in profits but faces questions over future leadership after CEO's departure
The day ahead includes full year results from the London Stock Exchange, Mondi, Spire Healthcare and IMI
Spire Healthcare gets boost from Berenberg upgrade to ‘buy’
Hospital operator's shares surged as in-patient data revealed it be head and shoulders above the competition
Mediclinic won’t make a fresh swoop for Spire as takeover talks break down
Mediclinic hinted last week that it was considering reviving its interest in Spire after having a £1.2bn offer rejected last month
FTSE 100 closes higher as pound firms; Shire top riser
The latest ONS data showed that retail sales grew 0.3% in October - ahead of the 0.1% economists had expected - which has boosted the blue chip retailers
B&M chairman Terry Leahy to be replaced by SuperGroup's Peter Bamford
B&M chairman Terry Leahy will be replaced by Peter Bamford, the current chairman of SuperGroup and deputy chairman of Spire Healthcare
Spire Healthcare rejects takeover offer from Mediclinic
Mediclinic wants to buy the rest of the shares in Spire Healthcare that it does not already own
Profit warning weighs on Renold; Digital Barriers, Ironveld fall
A look at some the biggest risers and fallers in London today
FTSE 100 closes at record high bolstered by weak pound on Brexit talks 'stalemate'
In a joint news conference held later in the day, Barnier admitted that some progress had been achieved on citizens' rights and Ireland's common travel area
Archive
Bank of England meeting key on retail Thursday, with updates due from Next, Morrison's, and Booker
Day ahead includes Bank of England Monetary policy meeting, UK retail sales data, updates from Next PLC, William Morrison Supermarkets PLC, and Booker PLC
Spire Healthcare reaches agreements with patients of rogue breast surgeon Ian Paterson
"These events took place in our hospitals, and this should not have happened," Spire said, in an unreserved apology to Paterson's victims.
Mediclinic's full year trading in line with expectations except Abu Dhabi
Mediclinic expects a £12mln contribution to full year profit from its stake in Spire Healthcare
FTSE shares end flat, give back record peaks, except Vesuvius
FTSE 100 stocks ends flat on Thursday after falling back from a fresh record high as shares in outsourcing group Capita slumped 9%
Investments and investor services
Can Cobham avoid a sixth profit warning when it releases full year results?
Cobham, Sportech, Travis Perkins, Capita and GoCompare are among the names on Thursday's list.
PREVIEW: What to expect from Spire Healthcare interims on Thursday
Investors will want to see signs that an anticipated pick up in growth will materialise in the second.
Week Ahead: Persimmon expected to shrug off Brexit fears
Approvals remained ahead of last year in the run-up to the EU membership referendum but what about after it?
Archive
Brokers: Jefferies foresees fall in consumer confidence
Lots of dark clouds are gathering for retailers, judging by the latest retail review from Jefferies. Also covered: GlaxoSmithKline, Aureus Mining, Spire Healthcare Group
RedX tipped for success as Cantor assesses pharmas
Cantor now rates RedX as a ‘buy’, and with a 105p target the broker sees some 150% upside to the current price of 41.5p.
Investments and investor services
Brokers: Goldman warns online is cannibalising store sales
Primark owner AB Foods, Debenhams, Next are among those in Thursday’s broker spotlight, along with RBS, Morgan Advanced Materials, Kingspan and Spire Healthcare.
Market: Lenders flat despite buy-to-let mortgage boost
London’s blue-chip stocks were relatively flat today,
Investments and investor services
Risers & Fallers: 88 Energy, HSS Hire, Pantheon Resources, Univision and more
Below are the main news-driven share price movements at 4pm.
Broker downgrades Spire after NHS cuts spark a full-year warning
Broker Jefferies reduces Spire to 'hold' from 'buy'
Investments and investor services
FTSE100 ends lower as miners and oil firms weigh
The FTSE100 plunged more than 100 points to 6,189 on Thursday.
Investments and investor services
Risers & Fallers: Motive Television, XLMedia, ECR Minerals, Kimberly Enterprises, Spire, Halfords
Below are the main news-driven share price movements at 4pm.
Archive
FTSE 100 crashes to eight month low
The top share index fell for the ninth day in a row and finished down 5.5% on the week.
Investments and investor services
FTSE 100 hit by double whammy from China and Greece
It's not quiet a triple digit fall - yet - for Footsie, but it is mighty close.
FTSE 100 falls for ninth day in a row
It's looking like a total capitulation by the bulls as fears grow for Asia-Pacific economic growth prospect
Risers & Fallers including Marechale Capital, Photonstar, Premier Oil, Glaxo, Fidelity China...
Below are the main new driven share price movements at 4pm.
Friday's agenda - healthcare in focus as Spire reports
The last day of the week and Spire Healthcare, the private hospital operator, is a notable reporter on the corporate front.
Investments and investor services
Week Ahead: Cairn Energy second half could be transformational
Deutsche Bank said the timing and drilling locations for three wells in Senegal could be unveiled. While they are in deep waters off the coast of west Africa, they aren’t technically challenging.
Investments and investor services
FTSE 100 ends higher as a Greece deal appears to be back on
European Commission president Jean-Claude Juncker said new proposals submitted by Greece to its creditors were a “basis for progress”.
Investments and investor services
FTSE 100 high on cocktail of Greek optimism and M&A
We're not there yet, but EU big-wigs were making welcoming noises about the latest debt crisis proposals from Greece
Investments and investor services
Market movers: ReNeuron, Cap-XX, Creightons, Rambler, Gemfields, Styles & Wood
Investors were still buying in after Styles & Wood reported a tripling of underlying profit before tax for 2014 on Friday.
FTSE 100 ends higher as a Greece deal appears to be back on
European Commission president Jean-Claude Juncker said new proposals submitted by Greece to its creditors were a “basis for progress”.